Akums Drugs & Pharmaceuticals Ltd
NSE: AKUMS BSE: 544222
₹527.90
(-2.30%)
Tue, 19 May 2026, 00:10 pm
Market Cap85.14B
PE Ratio25.40
Dividend0
Akums Drugs & Pharmaceuticals Cashflow
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Deprecation and amortization | -698.41M | -946.79M | -1.13B | -1.26B | -1.53B |
| Accumulated depreciation, total | -3.83B | -4.60B | -5.39B | -6.47B | -7.84B |
| Cash from operating activities | 1.32B | 275.75M | 1.44B | 4.67B | 4.62B |
| Funds from operations | 2.73B | 3.79B | 1.78B | 4.17B | 4.28B |
| Net income (cash flow) | 1.23B | -2.53B | 948.55M | -40.35M | 3.38B |
| Depreciation & amortization (cash flow) | 698.41M | 946.79M | 1.13B | 1.26B | 1.53B |
| Depreciation/depletion | 657.32M | 916.93M | 1.11B | 1.24B | 1.51B |
| Amortization | 41.09M | 29.86M | 18.52M | 21.11M | 26.50M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 312.86M | 4.78B | -847.04M | 3.37B | -702.51M |
| Changes in working capital | -1.41B | -3.52B | -343.34M | 498.67M | 334.70M |
| Cash from investing activities | -1.16B | -2.39B | -3.13B | -3.42B | -5.73B |
| Capital expenditures | -828.10M | -2.58B | -3.29B | -3.11B | -2.72B |
| Capital expenditures - fixed assets | -828.10M | -2.58B | -3.29B | -3.11B | -2.72B |
| Capital expenditures - other assets | — | — | — | — | — |
| Cash from financing activities | -864.44M | 2.45B | 1.65B | -645.84M | 1.01B |
| Free cash flow | 494.63M | -2.30B | -1.85B | 1.55B | 1.90B |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800